Hamilton Thorne Ltd. (TSX: HTL)

Market Cap	211.03M
Revenue	67.23M
Net Income	-607.02K
Shares Out	151.82M
EPS	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,200
Open	1.400
Previous Close	1.380
Day's Range	1.390 - 1.400
52-Week Range	1.050 - 1.670
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing se...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Dr. Ekaterina Torchilin MBA, Ph.D.
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: HTL